Latest news with #MichaelLau
Business Upturn
2 days ago
- Health
- Business Upturn
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
FRANKFURT, Germany, Aug. 08, 2025 (GLOBE NEWSWIRE) — In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, accessible diagnostic tool at the point of care. As cases continue to rise across tropical and subtropical regions, timely detection and differentiation from other arboviral infections like Dengue and Zika remain critical. The test, based on immunochromatographic technology, enables reliable qualitative detection of Chikungunya-specific antibodies in human serum, plasma, or whole blood. This addition strengthens Anbio's infectious disease diagnostics portfolio and supports public health efforts in responding to emerging outbreaks. In parallel, Anbio is advancing the boundaries of decentralized molecular diagnostics with the launch of its new AP-100 Ultra-Fast PCR system, designed to bring laboratory-grade testing capabilities directly to the point of care. 'Outbreaks demand speed. The AP-100 collapses hours of traditional PCR into minutes, without compromising accuracy,' said Michael Lau, CEO of Anbio Biotechnology. The AP-100 utilizes an advanced microfluidic thermal cycling system combined with high-efficiency enzymatic amplification chemistry, enabling direct processing of swab samples without the need for nucleic acid extraction. Its integrated design streamlines sample-to-result workflows, making it well-suited for deployment in both centralized laboratories and decentralized, point-of-care environments. Key highlights: 15-minute PCR results from raw sample to answer Extraction-free workflow with no hazardous reagents Compact 668g device for mobile or near-patient testing Broad pathogen coverage, including COVID-19, Flu A/B, RSV, MP, and ADV Lab-comparable accuracy validated against mainstream PCR platforms While initially focused on respiratory infections, the AP-100 is designed as a flexible molecular platform. In line with its global infectious disease strategy, Anbio is expanding the assay portfolio to include tests for tuberculosis (TB) and human papillomavirus (HPV), extending its role from rapid outbreak response to sustained disease management. 'Whether it's vector-borne fevers or respiratory pandemics, we believe diagnostics should move as fast as the threat,' Lau added. With its combination of speed, mobility, and lab-grade precision, Anbio's new-generation POCT PCR system strengthens healthcare capacity in both well-resourced and resource-limited settings, advancing global preparedness for infectious disease threats. About Anbio Biotechnology Anbio Biotechnology is a globally oriented in vitro diagnostics (IVD) company providing a broad range of solutions, including immunofluorescence, dry chemistry, chemiluminescence, molecular diagnostics, rapid testing and veterinary diagnostics. With operations across multiple regions, the company works to enhance the availability of reliable and timely diagnostics, supporting better decision-making in healthcare settings worldwide. For more information about Anbio Biotechnology, follow us for the latest news and updates. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
South China Morning Post
29-05-2025
- Business
- South China Morning Post
Who's got the next Labubu? Hong Kong creators eye a slice of ‘goods economy' pie
As an avid collector of modern and contemporary art, Hong Kong fintech millionaire Kenneth's latest splurge is a whimsical luxury watch with a HK$2 million (US$242,000) price tag. Advertisement The limited edition timepiece by Swiss watchmaker Audemars Piguet features Companion, the toy character with a skull, crossbones and gloves by American Brian Donnelly, better known as Kaws. The artist and designer first turned his Companion character into toys in 1999, selling out immediately. It is now one of the most valuable intellectual property (IP) products globally. Kenneth's love for Kaws has seen him spending more than HK$3.2 million on about 40 toys over the years, including two 1.2-metre (four-foot) Companion figures, a dozen smaller figurines and his most recent acquisition, the watch. Only 250 Kaws watches were made. Kenneth's superfan status landed him an invitation to the launch party in Switzerland last November. Advertisement His other favourite artist in the IP 'goods economy' is Hong Kong sculptor Michael Lau Kin-man, who started making figurines in the 1990s with elements of street culture and is often regarded as the 'godfather' of designer toys in the city. 'They aren't just creating objects, they're telling bold stories and challenging the norm,' he said. Kenneth, who is in his forties and asked to be identified by his first name only, started his online payment business in the late 1990s.
Yahoo
15-05-2025
- Business
- Yahoo
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions
— Accelerating Expansion Across Human and Veterinary Health Through Innovation and Strategic Collaboration BRUSSELS, May 15, 2025 /PRNewswire/ -- Anbio Biotechnology, a global leader in in-vitro diagnostic (IVD) technologies, is pleased to announce its participation in three major international exhibitions this May: EuroMedLab 2025 in Brussels, AVA Conference 2025 in Sydney, and the 47th ACMTT 2025 in Bangkok. These events reflect Anbio's strategic commitment to expanding its global footprint across human and animal healthcare, building new partnerships, and sharing its vision for accessible, high-performance diagnostics. As healthcare systems around the world seek faster, more accurate, and decentralized testing solutions, Anbio is well-positioned to meet this demand through a diversified portfolio and expanding global network. "These exhibitions are not just product showcases—they represent Anbio's mission to reshape diagnostics through collaboration, innovation, and accessibility," said Michael Lau, CEO of Anbio Biotechnology. "We look forward to connecting with partners and professionals who share our vision of smarter, more inclusive healthcare." At all three exhibitions, Anbio will feature its comprehensive diagnostic portfolio designed to meet the needs of both clinical and veterinary professionals. Key solutions include: Fluorescence Immunoassay (FIA) Systems: Supports 90 test items, offering rapid and quantitative detection across a broad range of clinical areas—including cardiac markers, hormones, infectious diseases, inflammation, tumor markers and others. Dry Chemistry Analyzers: Compact and user-friendly systems designed for essential biochemical testing at the point of care. Utilizing independent test strip-based reagents, offers a simpler, maintenance-free testing experience—ideal for decentralized settings such as community clinics, mobile units, and veterinary practices. Rapid Test Kits: Lateral flow and immunoassay-based kits for on-site diagnostics。 Molecular Diagnostic System: Offers a versatile molecular diagnostics portfolio, including LAMP-based Rapid Mdx System, and real-time RT-PCR reagents. With room temperature-stable reagents and streamlined protocols, these solutions enable faster, more accessible nucleic acid detection. Veterinary Diagnostics Suite: Provides a comprehensive diagnostic solution for veterinarians, integrating immunoassays, biochemical testing, and molecular diagnostics. This all-in-one approach supports accurate, efficient, and on-site decision-making for a wide range of companion animal health needs. These innovations are built on a shared foundation of accuracy, speed, and usability, enabling deployment in hospitals, labs, mobile units, veterinary clinics, and remote field settings. Global Vision, Local Action With product registrations in over 100 countries and a growing network of international partners, Anbio continues to pursue a global strategy of innovation, collaboration, and commercialization. Its participation in EuroMedLab, AVA, and ACMTT underscores a commitment to engaging with local markets while driving global standards. As part of this initiative, Anbio is actively seeking distribution partners, research collaborators, and strategic investors to expand diagnostic access and co-develop market-specific solutions. About Anbio Biotechnology Anbio Biotechnology is a globally oriented IVD company focused on empowering healthcare professionals through innovative diagnostic solutions. Its portfolio spans immunofluorescence, dry chemistry, chemiluminescence, molecular diagnostics, and rapid testing. With strong R&D capabilities and a presence in over 100 countries, Anbio is dedicated to building a healthier world through diagnostics that are fast, accurate, and accessible to all. For more information about the Anbio Biotechnology, follow us on social media for the latest news and updates. View original content: SOURCE Anbio Biotechnology Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Cision Canada
14-05-2025
- Business
- Cision Canada
Consensus to return to Hong Kong and make its debut in Miami in 2026
Consensus 2026 marks a significant milestone with its return to Hong Kong and debut in Miami, expanding the reach of the world's longest-running and most influential crypto conference. Following a sold-out debut in 2025, Consensus Hong Kong returns from February 10–12, 2026, convening global leaders to accelerate cross-border innovation and drive East-West collaboration while boosting the Hong Kong economy. Consensus Miami debuts May 5–7, 2026, at the iconic Miami Beach Convention Center bringing three days of high impact programming, top tier dealmaking and cultural convergence to North America's crypto capital. Both events will feature Consensus's signature top-flight programming curated by CoinDesk, as well as a dynamic show floor of industry leading sponsors alongside specialized experiential activations. Also returning is the world-renowned Consensus Hackathon and CoinDesk PitchFest competition, connecting attendees, developers and startups with the most influential voices in crypto, blockchain, Web3 and AI. HONG KONG and MIAMI, May 14, 2025 /CNW/ -- CoinDesk, the most trusted media, events, indices, and data platform for the global crypto economy, today announced the next chapters for Consensus, the world's longest-running and most influential crypto and blockchain gathering. Following its triumphant debut in 2025, Consensus will return to Hong Kong from February 10–12, 2026, and for the first time, Miami from May 5–7, 2026. This expansion marks a significant milestone for the conference as it continues to grow its global footprint. Hong Kong: A proven hub for innovation Building on the success of its sold-out inaugural event, which attracted nearly 10,000 attendees from over 100 countries and contributed an estimated HK$275 million to the local economy, Consensus Hong Kong 2026 is set to accelerate the dialogue between East and West and capture the next wave of innovation, adoption, and deal-making in crypto, AI, and blockchain. The 2025 debut witnessed industry-altering announcements from regulators and financial institutions, featured 300+ high-caliber speakers from the Hong Kong government, global regulatory bodies, and industry leaders including Binance, Circle, Coinbase, and Google. The 2026 event will occupy the largest floor of the Hong Kong Convention and Exhibition Centre, delivering an expanded experience with signature programming, startup and developer competitions, and networking opportunities. Consensus also included marquee special events across iconic Hong Kong venues, and fostered 350+ side events during its debut year. Michael Lau, Chairman of Consensus, expressed his enthusiasm, "The overwhelming success of Consensus Hong Kong 2025 was a testament to Hong Kong's status as a leading global FinTech hub and its unique role as a gateway to Asia. This vibrant city, with its dynamic ecosystem and entrepreneurial spirit, has proven the demand for a world-class conference. We are excited to return with an even larger platform to host the most influential voices in blockchain, Web3, and AI, and to create unparalleled networking opportunities." Miami: A new frontier for Consensus As Consensus expands its global reach, 2026 will not only mark a return to Hong Kong but also introduce Miami, Florida, as a new host city from May 5–7 at the Miami Beach Convention Center. Located in one of the world's leading tech and crypto hubs, and a direct gateway to Latin America, positioning the event at the strategic crossroads of global capital, talent, and innovation. The Miami event is poised to facilitate consequential conversations and business opportunities while serving as a pivotal meeting point for innovators and leaders from around the world. Brad Spies, Managing Director of Consensus, said, "Consensus has a long history of bringing together diverse groups from across crypto, finance, tech, policy, AI and culture to connect, do business, and showcase the future. Miami allows us to supercharge Consensus, and advance Web3 in one of the most fun and attractive cities on the planet." Both events will feature Consensus's signature top-flight programming curated by CoinDesk, massive B2B and networking engines, and best in class events and production. There will be a special focus on continuing the success of its Hackathon and PitchFest, which draw the most promising tech talent and early-stage Web3 start-ups from around the world. Attendees can look forward to a series of dynamic discussions, iconic moments, and unforgettable experiences in two of the world's most vibrant cities. Tickets for Consensus Hong Kong 2026 and Consensus Miami 2026 are now available. Secure your spot today to be part of the world's largest and longest-running crypto festival. About Consensus Consensus by CoinDesk is the world's longest running and most influential gathering for the crypto, blockchain, and AI industries. Bringing together industry leaders, policymakers, and innovators, it helps you understand the future of digital assets with discussions on key topics such as DeFi, Web3, AI, the evolving regulatory landscape and more. With a mix of panels, keynotes, and networking opportunities, Consensus provides a platform to explore the latest trends shaping the digital economy. Whether you're an industry veteran or just entering the space, this event offers valuable insights and connections in a rapidly evolving field. About CoinDesk CoinDesk is the most trusted media, events, indices, and data company for the global crypto economy. Since 2013, when the price of Bitcoin was $50, CoinDesk Media has led the story of the future of money and investing, illuminating the transformation in society and culture that comes with it. Our award-winning team of journalists delivers news and unparalleled insights that bring transparency, comprehension, and context. CoinDesk gathers the global crypto, blockchain, and Web3 communities at annual events such as Consensus, the world's largest and longest-running crypto festival. CoinDesk Indices offers expertise in digital asset indices, data, and research to educate and empower investors. In November 2023, CoinDesk was acquired by Bullish Group. CoinDesk operates as an independent subsidiary and abides by a strict set of editorial policies. For more information on CoinDesk media and events, please visit Forward-Looking Statements This press release may include "forward-looking statements" relating to future events or the Bullish Group's future financial or operating performance, business strategy, and potential market opportunity. Such forward-looking statements are based upon estimates and assumptions that, while considered reasonable by the Bullish Group, are inherently uncertain and are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. You should not place undue reliance on any such forward-looking statements, which speak only as of the date they are made, and the Bullish Group undertakes no duty to update these forward-looking statements.
South China Morning Post
02-03-2025
- Entertainment
- South China Morning Post
Blackpink's Lisa and influencer Bryanboy love collectibles: even Thai Prime Minister Paetongtarn Shinawatra is into the burgeoning designer toy scene started by 90s Hong Kong designers
Fashion is toying with a new craze. In the past few months social media has been awash with images of editors, celebrities and influencers showing off their latest plush toys, from Labubu dolls (Bryanboy and Blackpink's Lisa are fans, and the company has collaborated with fashion labels such as Pronounce) to Jellycats. Galeries Lafayette in China has pioneered a new 'comfort shopping' area called Gift Market, which is packed with customers shopping for cuddly toys such as TeddyTales. Even Bottega Veneta played homage to the trend at its spring/summer 2025 show, where seats were replaced with a playful menagerie of animal-shaped beanbag chairs chosen specifically for each guest. Labubu dolls are popular keychains and bag charms. Photo: Handout Advertisement It's not just the fashion world that is embracing these symbols of youth though. Grown-ups everywhere are recapturing their childhood by investing in toys that bring them joy. Chinese firm Pop Mart, which sells collectible designer toys including Labubu and the Molly series, achieved record sales and profits last year. Experts are predicting that the collectable toy market will reach US$38.2 billion by 2034. 'The democratisation of prices has encouraged a broader audience to own collectable toys. For women there's been a rise in collectable bag charms driven by K-pop. Blind-box toys – where you buy a sealed box and don't know which specific toy from a series you are getting – are also popular, especially as people enjoy sharing on social media,' says Bryan Fok, head of supply acquisition, Greater China, for StockX, which sells various collectibles. Michael Lau's design for Baby Milo, created for Bape's 25th anniversary. Photo: Handout So how did toys transition from playpens into must-have accessories and collectible keepsakes for adults? Experts say the trend originated in Hong Kong, a global centre for toy manufacturing in the 1970s and 80s. A wave of creativity followed in the 90s, when local artists like Eric So and Michael Lau pioneered a new category of toys that embraced innovative design and modern culture, attracting an entirely new audience. Amuseables Val & Tina Love Locks by Jellycat. Photo: Handout 'At the time, street culture was booming,' says Lau, who has been dubbed the 'Godfather of the Designer Toy'. 'My painting exhibitions were not so well received, and I was thinking about the next step in my creative journey. I thought, why not combine my passion for toy collecting with street culture to create a medium of my own, and present a different version of art?' Inspired by the popularity of G.I. Joe action figures, Lau launched The Gardener series in 1999, a limited edition, adult-focused collection of 12-inch figurines that showcased toys as a new art medium. Collections from other artists such as So – whose series of collectable Bruce Lee figurines blurred the lines between art, design and objects – became just as popular. It wasn't long before more collectable toys began to emerge from Japan. While old-school creations such as Hello Kitty, Little Twin Stars and Pokémon attracted a younger audience, newer designs immediately struck a chord with an older crowd.
